Skip to main content
. 2022 Aug 27;62(9):391–399. doi: 10.2176/jns-nmc.2022-0103

Fig. 5.

Fig. 5

Results of the molecular reclassification of 303 diffuse gliomas from the retrospective cohort according to the World Health Organization (WHO) 2021 classification. The diagram shows the diagnostic change between the diagnosis based on the WHO 2016 classification (left) and the diagnosis based on the WHO 2021 classification (right).